Cross Country Healthcare (CCRN) Misses Q4 EPS by 8c, provides guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q4 EPS of ($0.06), $0.08 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $236.76 million versus the consensus estimate of $254.31 million.

GUIDANCE:

Cross Country Healthcare sees Q1 2026 EPS of ($0.06)-($0.04), versus the consensus of $0.01. Cross Country Healthcare sees Q1 2026 revenue of $235-240 million, versus the consensus of $256.5 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Berenberg Starts Natwest Group PLC (NWG:LN) (NWG) at Buy
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank